Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients

The Journal of Clinical Psychiatry
R J KavoussiJ A Johnston

Abstract

A sustained-release formulation of bupropion (bupropion SR), developed with an improved pharmacokinetic profile to permit less frequent dosing than the immediate-release form, has not been evaluated in active comparator trials. This randomized, double-blind, parallel-group trial was conducted to compare the efficacy and safety of bupropion SR and sertraline. Outpatients with moderate to severe major depressive disorder (DSM-IV) received bupropion SR (100-300 mg/day) or sertraline (50-200 mg/day) for 16 weeks. Psychiatric evaluations, including the Hamilton Rating Scale for Depression (HAM-D), the Hamilton Rating Scale for Anxiety (HAM-A), the Clinical Global Impressions scale for Severity of Illness (CGI-S), and for Improvement (CGI-I) were completed, and adverse events were assessed in the clinic periodically throughout treatment. Patients' orgasm function was also assessed. Mean HAM-D, HAM-A, CGI-I, and CGI-S scores improved over the course of treatment in both the bupropion SR group and the sertraline group; no between-group differences were observed on any of the scales. Orgasm dysfunction was significantly (p < .001) more common in sertraline-treated patients compared with bupropion SR-treated patients. The adverse events ...Continue Reading

Citations

Jun 1, 2012·Current Psychiatry Reports·Gerald GartlehnerRichard A Hansen
Dec 21, 2000·Journal of Affective Disorders·S A MontgomeryJ Zajecka
Mar 4, 2000·Journal of Affective Disorders·S H KennedyR M Bagby
Feb 21, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Timothy PetersenMaurizio Fava
Mar 16, 2002·Journal of Sex & Marital Therapy·Michael J GitlinLynn Fairbanks
Jan 1, 2010·Drug, Healthcare and Patient Safety·Agnes HigginsAileen M Lynch
Dec 7, 2002·CNS Drugs·Gin S MalhiShahzad Salim
Jul 20, 2005·Primary Care Companion to the Journal of Clinical Psychiatry·Maurizio FavaJ Andrew Johnston
Apr 9, 2001·Journal of Affective Disorders·A J RushA Metz
May 18, 2000·Clinical Therapeutics·A J Rothschild
Oct 18, 2007·Expert Review of Neurotherapeutics·Chi-Un PaeChul Lee
Oct 3, 2006·Expert Review of Neurotherapeutics·Kevin F FoleyRichard E Kast
Feb 21, 2007·Expert Opinion on Pharmacotherapy·Anita H Clayton
Apr 1, 2003·Expert Opinion on Investigational Drugs·Frank P BymasterPierre V Tran
May 18, 2000·Brain Injury : [BI]·R D TolatH Avella
Sep 2, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Gerald GartlehnerKathleen N Lohr
Jan 29, 2011·The Journal of Sexual Medicine·Jennifer L Moll, Candace S Brown
Nov 7, 2007·The Urologic Clinics of North America·Antoine MakhloufCraig S Niederberger
Jun 26, 2007·Pharmacology, Biochemistry, and Behavior·Hassan H LópezBenjamin Ragen
Mar 17, 2007·The Psychiatric Clinics of North America·Andrew A NierenbergMaurizio Fava
Dec 3, 2003·Seminars in Cutaneous Medicine and Surgery·Chai Sue Lee, John Koo
Jan 18, 2006·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·George I Papakostas
Aug 23, 2005·Dermatologic Clinics·Chai Sue Lee, John Koo
Apr 6, 2004·The Psychiatric Clinics of North America·Robert L FindlingChristine Demeter
Oct 6, 2000·Biological Psychiatry·M E Thase, G S Sachs
Jul 7, 2010·Neuroscience and Biobehavioral Reviews·Michael T Treadway, David H Zald
Apr 16, 2013·Pharmacology, Biochemistry, and Behavior·Nandkishor R KotagaleBrijesh G Taksande
Nov 14, 2001·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·A W PoretJ W Kwong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.